Skip to main navigation
Skip to search
Skip to main content
Sort by
Nursing and Health Professions
Metabolic Syndrome X
100%
Medical Examination
56%
Cohort Analysis
49%
Chronic Kidney Failure
39%
Decision Trees
39%
Receiver Operating Characteristic
37%
Preventive Medicine
36%
Area under the Curve
31%
End Stage Liver Disease
30%
Electronic Medical Record
30%
Health Care
30%
Malignant Neoplasm
30%
Obesity
30%
Systematic Review
30%
Supplementation
30%
Pregnancy Diabetes Mellitus
30%
Birth Weight
30%
Meta Analysis
30%
Elastograph
24%
Urea Nitrogen Blood Level
22%
Logistic Regression Analysis
20%
Prothrombin Time
20%
Chronic Liver Disease
20%
International Normalized Ratio
20%
Diseases
19%
Random Forest
19%
Unsupervised Machine Learning
13%
Supervised Machine Learning
13%
Health Care Management
12%
Mortality Rate
9%
C Reactive Protein
9%
Hazard Ratio
9%
Healthy Lifestyle
9%
Health Status
9%
Odds Ratio
9%
Decision-Making
9%
Telemedicine
9%
Medical Record
9%
Bilirubin
9%
Patient Education
9%
Clinical Practice
9%
Proportional Hazards Model
9%
Public Health
9%
Creatinine
9%
Public Health Informatics
9%
Health Care Personnel
9%
Chronic Disease
9%
High Birth Weight
8%
Confidence Interval
8%
Placebo
8%
Medicine and Dentistry
Metabolic Syndrome
100%
Preventive Medicine
66%
Health Care
60%
Medical Examination
56%
Retrospective Cohort Study
49%
Chronic Kidney Disease
39%
Area under the Curve
31%
Electronic Patient Record
30%
Malignant Neoplasm
30%
End Stage Liver Disease
30%
4 Iodo 2,5 Dimethoxyamphetamine
30%
FibroScan
24%
Prediction Model
23%
Blood Urea Nitrogen
22%
Logistic Regression Analysis
20%
Chronic Liver Disease
20%
Prothrombin Time
20%
Diseases
15%
Body Mass Index
11%
Mortality Rate
9%
Creatinine
9%
Proportional Hazards Model
9%
Medical Record
9%
Bilirubin
9%
Awareness
9%
Health Status
9%
Medical Informatics
9%
Telemedicine
9%
Education
9%
Healthy Lifestyle
9%
Odds Ratio
9%
Health Care Personnel
9%
Hazard Ratio
9%
Chronic Disease
9%
Clinician
9%
Public Health
9%
Chronic Disorder
9%
Decision Making
9%
C Reactive Protein
9%
Glycated Hemoglobin
7%
Hemoglobin A1c
5%
Kidney Function
5%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
38%
Intervertebral Disk Degeneration
30%
Pregnancy Diabetes Mellitus
30%
Metabolic Syndrome X
30%
Diabetes Mellitus
30%
Urate
30%
Hyperuricemia
30%
Obesity
30%
Xanthine Oxidase Inhibitor
13%
Febuxostat
9%
Reactive Oxygen Metabolite
8%
Placebo
8%
Glucose
8%
Adverse Event
6%
Lesinurad
6%
Topiroxostat
6%
Terminalia bellirica
6%
Adverse Effect
6%
